1. Cucolo, Lisa, Chen, Qingzhou, Qiu, Jingya, Shi, Junwei, Minn, Andy J. . The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade. In Immunity, 55, 671-685.e10. doi:10.1016/j.immuni.2022.03.007. https://pubmed.ncbi.nlm.nih.gov/35417675/
2. Zelic, Matija, Pontarelli, Fabrizio, Woodworth, Lisa, Hammond, Timothy, Ofengeim, Dimitry. . RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis. In Cell reports, 35, 109112. doi:10.1016/j.celrep.2021.109112. https://pubmed.ncbi.nlm.nih.gov/33979622/
3. Newton, Kim. 2015. RIPK1 and RIPK3: critical regulators of inflammation and cell death. In Trends in cell biology, 25, 347-53. doi:10.1016/j.tcb.2015.01.001. https://pubmed.ncbi.nlm.nih.gov/25662614/
4. Ito, Yasushi, Ofengeim, Dimitry, Najafov, Ayaz, Ravits, John, Yuan, Junying. . RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. In Science (New York, N.Y.), 353, 603-8. doi:10.1126/science.aaf6803. https://pubmed.ncbi.nlm.nih.gov/27493188/
5. Karunakaran, Denuja, Turner, Adam W, Duchez, Anne-Claire, McPherson, Ruth, Rayner, Katey J. 2020. RIPK1 gene variants associate with obesity in humans and can be therapeutically silenced to reduce obesity in mice. In Nature metabolism, 2, 1113-1125. doi:10.1038/s42255-020-00279-2. https://pubmed.ncbi.nlm.nih.gov/32989316/
6. Cao, Ze, Min, Xia, Xie, Xingxing, Li, Ying, Yuan, Junying. 2024. RIPK1 activation in Mecp2-deficient microglia promotes inflammation and glutamate release in RTT. In Proceedings of the National Academy of Sciences of the United States of America, 121, e2320383121. doi:10.1073/pnas.2320383121. https://pubmed.ncbi.nlm.nih.gov/38289948/
7. Coornaert, Isabelle, Puylaert, Pauline, Marcasolli, Giullia, De Meyer, Guido R Y, Martinet, Wim. 2021. Impact of myeloid RIPK1 gene deletion on atherogenesis in ApoE-deficient mice. In Atherosclerosis, 322, 51-60. doi:10.1016/j.atherosclerosis.2021.02.021. https://pubmed.ncbi.nlm.nih.gov/33706083/